Perspective Therapeutics

Perspective Therapeutics is a medical technology and radiopharmaceutical company that pioneers advanced therapeutic applications for systemic cancer. The company is the sole producer of cesium-131 brachytherapy seeds and possesses proprietary technology to deliver potent alpha radiation to cancer cells using the isotope lead-212 via specialized targeting peptides. It is also developing complementary imaging diagnostics incorporating the same targeting peptides, offering opportunities for personalized treatment and optimized patient outcomes. This "theranostic" approach enables the visualization of specific tumors followed by targeted treatment, potentially enhancing efficacy while minimizing the toxicity associated with many other types of cancer therapies.